Lead Product(s) : Pimozide
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Undisclosed
Sponsor : Applied Biology
Deal Size : Inapplicable
Deal Type : Inapplicable
Jupiter Wellness Initiates Clinical Trial for Potential New Treatment for Tinnitus
Details : This study aims to investigate if the dopamine receptor antagonist Pimozide can be used effectively treat COVID-19 for tinnitus, emergent symptoms lasting longer than 4 weeks since onset.
Product Name : JW-600
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 10, 2022
Lead Product(s) : Pimozide
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Undisclosed
Sponsor : Applied Biology
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Streptococcus Pneumoniae Vaccine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Undisclosed
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Blue Water Licenses Patent Rights for bacterial Vaccine Development
Details : Blue Water Vaccines has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
October 02, 2020
Lead Product(s) : Streptococcus Pneumoniae Vaccine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Undisclosed
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Licensing Agreement